𝔖 Bobbio Scriptorium
✦   LIBER   ✦

95 SEQUENTIAL USE OF TEMSIROLIMUS (TEM) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): SAFETY AND EFFICACY FOLLOWING FAILURE OF RECEPTOR TYROSINE KINASE INHIBITOR (TKI) TREATMENT

✍ Scribed by S. Weikert; C. Kempkensteffen; K. Zimmermann; V. Grünwald; A. Floercken; J. Westermann; K. Miller; U. Keilholz; M. Johannsen


Book ID
119620838
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
81 KB
Volume
9
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES